Incorporation of Silver into Sulfate Groups Enhances Antimicrobial and Antiviral Effects of Fucoidan

Mar Drugs. 2024 Oct 29;22(11):486. doi: 10.3390/md22110486.

Abstract

The COVID-19 pandemic has significantly impacted our daily lives. Routine infection-control measures present an effective preventive strategy for a new infectious disease outbreak. Fucoidan, a fucose-rich sulfated polysaccharide found in brown algae, exhibits antiviral activity. Moreover, fucoidan exerts an antimicrobial effect; however, it requires considerably higher concentrations than those needed for its antiviral effect. In this study, we aimed to enhance the antimicrobial activity of fucoidan and prepared a fucoidan silver salt (Ag-Fuc) by incorporating silver ions into the sulfate groups of Yakult Fucoidan derived from Cladosiphon okamuranus Tokida. The fucoidan exhibited a weak inhibitory effect on Escherichia coli growth at significantly higher concentrations, whereas Ag-Fuc inhibited the growth of E. coli and Staphylococcus epidermidis at concentrations comparable to those required for its antiviral effects. Moreover, Ag-Fuc inhibited the growth of Cladosporium cladosporioides. Infections of human cells with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and influenza A virus were more effectively inhibited by lower concentrations of Ag-Fuc compared with fucoidan. Overall, silver ions added to the sulfate groups induced strong antimicrobial activity and enhanced the antiviral effect of fucoidan. We suggest a wide application of Ag-Fuc as a routine preventive material to avoid new infectious disease pandemics.

Keywords: SARS-CoV-2; antibacterial activity; antifungal activity; antiviral activity; fucoidan; influenza virus; silver.

MeSH terms

  • Animals
  • Anti-Bacterial Agents / pharmacology
  • Anti-Infective Agents / pharmacology
  • Antiviral Agents* / pharmacology
  • COVID-19 Drug Treatment
  • Escherichia coli / drug effects
  • Humans
  • Microbial Sensitivity Tests
  • Phaeophyceae / chemistry
  • Polysaccharides* / pharmacology
  • SARS-CoV-2 / drug effects
  • Silver* / pharmacology
  • Staphylococcus epidermidis / drug effects
  • Sulfates / chemistry
  • Sulfates / pharmacology

Substances

  • fucoidan
  • Polysaccharides
  • Antiviral Agents
  • Silver
  • Anti-Infective Agents
  • Sulfates
  • Anti-Bacterial Agents

Grants and funding

This research received no external funding.